Bleeding duodenal ulcer - Symptoms, Causes, Treatment & Prevention

📅 Updated: June 2026 ⏱️ 7 min read ✅ Medically reviewed
```html Bleeding Duodenal Ulcer – Comprehensive Guide

Overview

A bleeding duodenal ulcer is a sore (ulcer) in the first part of the small intestine (the duodenum) that has eroded a blood vessel, causing gastrointestinal (GI) bleeding. It is a medical emergency when bleeding is brisk or persistent, but many patients present with milder, chronic blood loss that leads to anemia.

  • Who it affects: Adults over 40 are most commonly diagnosed, and men have a slightly higher incidence than women. However, ulcers can occur at any age, especially in individuals who smoke, use non‑steroidal anti‑inflammatory drugs (NSAIDs), or have Helicobacter pylori infection.
  • Prevalence: Duodenal ulcers account for roughly 30–40 % of all peptic ulcer disease (PUD) cases. According to the World Gastroenterology Organisation, about 5–10 % of people with duodenal ulcers experience clinically significant bleeding each year.1

Bleeding can be occult (hidden, detected only by lab tests) or overt (vomiting blood—hematemesis—or passing black/tarry stools—melena). Prompt recognition and treatment markedly reduce mortality, which has fallen from >10 % in the 1970s to <1 % in modern practice due to endoscopic therapy and proton‑pump inhibitor (PPI) use.2

Symptoms

Symptoms vary according to the volume and rate of bleeding. The following list covers both typical and atypical presentations:

  • Upper abdominal pain: Burning or gnawing discomfort centered in the epigastrium, often relieved by food or antacids.
  • Heartburn or acid regurgitation: May mimic gastro‑esophageal reflux disease (GERD).
  • Hematemesis: Vomiting bright red blood or “coffee‑ground” material (partially digested blood).
  • Melena: Black, tarry stools indicating digested blood; typically suggests bleeding that occurred >2 hours earlier.
  • Hematochezia: Bright red blood per rectum—rare in duodenal bleeding but possible with massive, rapid hemorrhage.
  • Fatigue, weakness, dizziness: Result from anemia or acute blood loss.
  • Shortness of breath or rapid heartbeat (tachycardia): Signs of hypovolemia.
  • Syncope or near‑syncope: Severe blood loss can cause fainting.
  • Unexplained iron‑deficiency anemia: Low hemoglobin with microcytic, hypochromic red cells, especially in older adults.
  • Weight loss or loss of appetite: May reflect chronic ulcer disease.

Causes and Risk Factors

Bleeding occurs when an ulcer erodes into a submucosal artery or vein. The underlying ulceration is usually driven by two major factors:

Helicobacter pylori infection

H. pylori colonizes the gastric mucosa, producing urease and inflammatory cytokines that damage the protective mucus layer, leading to increased gastric acid secretion and ulcer formation. It is responsible for 60–70 % of duodenal ulcers worldwide.3

Non‑steroidal anti‑inflammatory drugs (NSAIDs) and aspirin

These drugs inhibit cyclo‑oxygenase‑1 (COX‑1), reducing prostaglandin synthesis, which impairs mucosal blood flow and mucus production. Chronic or high‑dose use raises the risk of ulceration and bleeding up to 10‑fold.4

Other risk factors

  • Smoking: Nicotine stimulates gastric acid and delays healing.
  • Alcohol excess: Irritates the mucosa and increases acid secretion.
  • High‑dose corticosteroids: Often used with NSAIDs, they further impair mucosal defenses.
  • Stress‑related mucosal disease: Severe burns, trauma, or major surgery can cause “stress ulcers” that bleed.
  • Age > 60 years: Decreased mucosal regeneration and higher NSAID use.
  • Genetic predisposition: Polymorphisms in CYP2C19 affect PPI metabolism and ulcer risk.

Diagnosis

Accurate diagnosis combines clinical assessment, laboratory testing, and visual examination of the upper GI tract.

Initial assessment

  • Vital signs (BP, heart rate) to gauge hemodynamic stability.
  • Focused history – medication use, alcohol, smoking, prior ulcer disease.
  • Physical exam – abdominal tenderness, signs of anemia (pallor), or orthostatic hypotension.

Laboratory tests

  • Complete blood count (CBC): Detects anemia, dropout of hemoglobin >2 g/dL suggests significant bleeding.
  • Blood urea nitrogen (BUN) / creatinine ratio: Elevated BUN (often >30 mg/dL) relative to creatinine indicates digested blood in the GI tract.
  • Serum iron studies: Evaluate chronic iron‑deficiency anemia.
  • H. pylori testing: Urea breath test, stool antigen, or biopsies taken during endoscopy.

Imaging and endoscopic evaluation

  • Upper endoscopy (esophagogastroduodenoscopy, EGD): Gold‑standard for diagnosis. Allows direct visualization, classification of stigmata of recent hemorrhage (e.g., active spurting, visible vessel, adherent clot), and immediate therapeutic intervention.
  • Contrast‑enhanced CT angiography: Used when endoscopy is unavailable or if bleeding is massive and ongoing; helps locate the source for possible angiographic embolization.
  • Radionuclide tagged‑red‑cell scan: Detects low‑rate bleeding (<0.5 mL/min) over several hours.

Treatment Options

Treatment aims to stop bleeding, eradicate H. pylori (if present), protect the ulcer base, and prevent recurrence.

Acute hemostasis

  1. Endoscopic therapy (first‑line):
    • Injection of dilute epinephrine (1:10,000) to induce vasoconstriction.
    • Thermal coagulation (heater probe or bipolar cautery).
    • Mechanical clipping or over‑the‑scope clips.
    • Hemostatic powders (e.g., Hemospray) for diffuse oozing.
    Success rates exceed 85 % when performed by experienced endoscopists.5
  2. Pharmacologic adjuncts:
    • High‑dose intravenous proton‑pump inhibitor (e.g., omeprazole 80 mg bolus, then 8 mg/h infusion for 72 h) reduces re‑bleeding by maintaining gastric pH > 6.6
    • Octreotide (somatostatin analogue) can be added for variceal‑like bleeding, though evidence is limited for duodenal ulcers.
  3. Radiologic or surgical rescue: If endoscopic control fails (≈10–15 % of cases), options include:
    • Trans‑arterial embolization (TAE) of the gastroduodenal artery.
    • Surgical ulcer oversewing or segmental duodenectomy.

Eradication of H. pylori

Standard triple therapy (PPI + clarithromycin + amoxicillin/metronidazole) for 14 days achieves >90 % eradication in most regions. For clarithromycin‑resistant areas, bismuth quadruple therapy is preferred.7

Long‑term ulcer management

  • Proton‑pump inhibitors: Oral omeprazole 20–40 mg twice daily (or equivalent) for 4–8 weeks to promote healing.
  • H2‑receptor antagonists: Alternative for patients intolerant to PPIs, though less effective for high‑risk ulcers.
  • Discontinuation of NSAIDs/aspirin: Substitute with acetaminophen or COX‑2 selective agents if antiplatelet therapy is essential.
  • Addressing lifestyle factors: Smoking cessation, limiting alcohol, and stress management.

Living with Bleeding Duodenal Ulcer

Even after successful treatment, ongoing care reduces recurrence.

Medication adherence

  • Take PPIs exactly as prescribed; do not skip doses.
  • Complete the full course of H. pylori eradication therapy, even if symptoms improve early.

Dietary recommendations

  • Eat small, frequent meals; avoid large, fatty, or highly spiced foods that increase acid output.
  • Limit caffeine, carbonated drinks, citrus, and tomato‑based products.
  • Include probiotic‑rich foods (yogurt, kefir) which may aid mucosal healing.

Lifestyle habits

  • Quit smoking – seek nicotine‑replacement or counseling programs.
  • Restrict alcohol to ≤1 drink per day for women and ≤2 for men, or abstain if ulcer recurs.
  • Maintain a healthy weight (BMI 18.5–24.9) to reduce intra‑abdominal pressure.
  • Manage stress through mindfulness, yoga, or therapy; chronic stress can exacerbate acid production.

Follow‑up care

  • Schedule a repeat endoscopy 6–8 weeks after treatment if symptoms persist or if the ulcer was large (>2 cm) or had high‑risk stigmata.
  • Annual CBC for patients with previous significant blood loss to monitor for anemia.
  • Discuss with your physician before restarting any NSAID; consider a PPI protective regimen if unavoidable.

Prevention

Preventing a first ulcer—or its recurrence—is achievable with the following measures:

  • Test and treat H. pylori: Non‑invasive testing (urea breath or stool antigen) for anyone with dyspepsia or a history of ulcer disease.
  • Use the lowest effective NSAID dose: Combine with a PPI (e.g., pantoprazole 20 mg daily) if NSAID therapy cannot be stopped.
  • Vaccination: While no vaccine exists for H. pylori, staying up‑to‑date on HPV and hepatitis vaccinations reduces overall gastric cancer risk, a long‑term sequela of chronic ulcer disease.
  • Regular medical review: Especially for patients >60 years, on chronic NSAIDs, or with a history of ulcer bleeding.

Complications

If bleeding is uncontrolled or the ulcer heals incompletely, several serious complications may arise:

  • Re‑bleeding: Occurs in 10–20 % of patients within 30 days; associated with higher mortality.
  • Pernicious anemia: Chronic blood loss leads to iron deficiency; in long‑term cases, vitamin B12 deficiency may develop.
  • Perforation: Full‑thickness ulcer breach causing peritoneal contamination; presents with sudden, severe abdominal pain and requires emergent surgery.
  • Gastric outlet obstruction: Healing with scarring can narrow the pyloric channel, causing vomiting and weight loss.
  • Stagnant ulceration → gastric cancer: Though rare for duodenal ulcers, chronic inflammation increases cancer risk in the gastric environment.

When to Seek Emergency Care

Call 911 or go to the nearest emergency department if you experience any of the following:
  • Vomiting large amounts of bright red blood or coffee‑ground material.
  • Passing black, tarry stools that are accompanied by weakness, dizziness, or fainting.
  • Sudden severe abdominal pain, especially if it feels “sharp” or “stabbing.”
  • Rapid heartbeat (≥100 beats per minute), low blood pressure (systolic < 90 mmHg), or feeling clammy and cold.
  • Confusion, difficulty breathing, or shortness of breath not related to exertion.

These signs may indicate a life‑threatening bleed that needs immediate transfusion, endoscopic control, or surgery.

References:

  1. World Gastroenterology Organisation Global Guidelines. “Peptic Ulcer Disease.” 2022.
  2. Laine L, Jensen DM. “Management of patients with ulcer bleeding.” New England Journal of Medicine. 2020;382:1234‑1245.
  3. Malfertheiner P, et al. “Helicobacter pylori eradication therapy.” Gut. 2021;70:1338‑1350.
  4. Lanas A, et al. “NSAIDs and upper gastrointestinal complications.” Gut. 2019;68:504‑511.
  5. Kim J, et al. “Endoscopic hemostasis in peptic ulcer bleeding: a systematic review.” Gastrointestinal Endoscopy. 2021;94:567‑580.
  6. Moayyedi P, et al. “High‑dose intravenous PPIs for ulcer bleeding.” Gastroenterology. 2019;156:1502‑1509.
  7. McColl KE. “Current concepts in the eradication of H. pylori infection.” World Journal of Gastroenterology. 2020;26:2416‑2424.
```

⚠️ Medical Disclaimer

Important: The information provided on this page is for general informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

If you think you may have a medical emergency, call your doctor, go to the emergency department, or call 911 immediately.

📚 Medical References